Brochure Request: 4th Annual Patient Recruitment & Retention in Clinical Trials

Patient recruitment and retention in clinical trials is the leading bottleneck in the new drug development pipeline.

As the recruiting culture becomes more sophisticated and the forces affecting patient enrollment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrollment in clinical trials.

Achieving success in this environment requires trial sponsors to play a larger role in the recruitment process and to develop more collaborative working relationships with all stakeholders, including investigators and patients.

Key speakers:

Astellas, UK, Vice President, Medical Affairs and Health Economics

AstraZeneca, Sweden, MD, PhD, Associate Professor

Baxter, Austria, Medical Director, Europe

Bristol-Myers Squibb, Russia, Clinical Operations Manager

Eli Lilly, USA, Director, Global Enrolment Optimization

Johnson & Johnson, USA, Director, Global Clinical Operations

GlaxoSmithKline, France, Executive Director, Medical Affairs and Clinical Development

Novo Nordisk, Denmark, Vice President, Clinical Operations, Trial Management

Lundbeck, Belgium, Director, International ClinicalResearch - Paediatric Neuro-Psychiatry

Pfizer, India, Head, Clinical Research

Roche, Turkey, Head of Clinical Trials

Sanofi-Aventis, Portugal, Clinical Trials Director

University Hospital Gasthuisberg Leuven, Belgium, Department of Paediatrics

Key topics:

The ½ Day pre-conference workshop will focus on retention strategies. Patient non-compliance can run as high as 80% and up to 40% of patients are lost to follow up in a clinical trial costing time and money.
Bringing Patient Recruitment into the 21st Century is looking into developing a foward thinking approach, considering public perception with respect to clinical trials, and looking into web-based recruitment
Key Components of a Clinical Trial focuses on issues such as communication between pharma, investigator and patient, protocol design and in-house training
Analysing Patient Populations addresses feasibility assessments, orphan indications and looks in to paediatric clinical trial challenges. This is followed by Recruiting and Retaining Patients in Emerging Markets where challenges and opportunities in regions such as the CIS, Turkey and India are examined.

Who should attend:

Vice Presidents and Directors of:

Patient Recruitment, Patient Retention, Clinical Development, Clinical Operations, Clinical Trials, Clinical Marketing, Clinical Strategy, Clinical Project Management, Medical Affairs, Regulatory Affairs

Request brochure: